What is Abridge?
Abridge operates at the intersection of artificial intelligence and clinical practice, providing a sophisticated platform that records and transcribes medical conversations in real-time. By generating interactive, structured transcripts that highlight key medical points, the company bridges the communication gap between patients, families, and clinicians. This technology is designed to improve health outcomes by ensuring that critical information is captured accurately during both in-person and telemedicine appointments, thereby enhancing follow-through and patient understanding. Abridge's market position is bolstered by its integration into major healthcare systems, where it serves as a vital tool for reducing physician burnout and improving the quality of clinical documentation.
How much funding has Abridge raised?
Abridge has raised a total of $757.5M across 6 funding rounds:
Other Financing Round
$15M
Series A
$12.5M
Series B
$30M
Series C
$150M
Series D
$250M
Series E
$300M
Other Financing Round (2020): $15M with participation from Pillar, KdT Ventures, Union Square Ventures, University of Pittsburgh Medical Center, and Bessemer Venture Partners
Series A (2022): $12.5M led by Union Square Ventures, Wittington Ventures, and Bessemer Venture Partners
Series B (2023): $30M supported by Bessemer Venture Partners, Uc Investments, Scan Group, Mayo Clinic, Spark Capital, and LifePoint Health
Series C (2024): $150M featuring Mass General Brigham, Bessemer Venture Partners, CVS Health, Wittington Ventures, Kaiser Permanente, Lightspeed Venture Partners, Redpoint Ventures, and Union Square Ventures
Series D (2025): $250M backed by California Health Care Foundation, Elad Gil, Lightspeed Venture Partners, IVP, CapitalG, Bessemer Venture Partners, and CVS Health
Series E (2025): $300M with participation from Lightspeed Venture Partners, CVS Health, and Andreessen Horowitz
Key Investors in Abridge
Lightspeed Venture Partners
A global multistage venture capital firm that invests in early and growth-stage technology companies across sectors such as enterprise software, consumer, fintech, and infrastructure.
CVS Health
A diversified healthcare company providing pharmacy care, health benefits, and consumer health solutions, focused on improving access and health outcomes.
Andreessen Horowitz
A prominent private American venture capital firm that invests in both early-stage start-ups and established growth companies across the technology landscape.
What's next for Abridge?
With the successful completion of its latest funding round, Abridge is well-positioned to solidify its dominance in the digital health space. The strategic focus will likely shift toward deepening its integration with electronic health record (EHR) systems and expanding its AI capabilities to support more complex clinical decision-making processes. As the company scales, it will continue to leverage its partnerships with major healthcare organizations to refine its models and ensure compliance with evolving medical standards. The influx of capital provides the necessary runway to pursue aggressive market penetration, potentially setting the stage for future expansion into international markets or new specialized medical domains.
See full Abridge company page
